title: VII. Are lymphomas driven by epigenetic lesions?
authors.affiliation: Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.
authors.forename: Isaac W
authors.initials: IW
authors.lastname: Boss
authors.affiliation: Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA.
authors.forename: Ari M
authors.initials: AM
authors.lastname: Melnick
mesh_terms: D044127:Epigenesis, Genetic; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D008297:Male; D009363:Neoplasm Proteins / Q000096:biosynthesis* / Q000235:genetics
chemical_list: D009363:Neoplasm Proteins
keywords: B cell; CBP; EZH2; KMT2D; P300; clinical treatment strategies; epigenetic modifier mutations; epigenetic regulation; lymphoma